Search

everythinglearnresearchcommunity

for

Search:↓

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Avoiding certain nutrients and drugs may help manage pemphigus.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Female and male AGA are different diseases.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Most classic movie villains have skin conditions, unlike the heroes, which may cause bias against real people with similar conditions.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Most women with weird scalp feelings had neck spine problems, and some got better with gabapentin treatment.

Stem cells and their surrounding environment in hair follicles work closely together, affecting hair growth and having implications for cancer and tissue regeneration.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

FDG PET/CT scans can change cancer treatment plans for dogs.

Early balding at 40 increases prostate cancer risk.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.